The cellular protein la functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated gag

mBio

Volumn 2, Issue 1, 2011, Pages

  Nitta, Takayuki ^a,b   Tam, Raymond ^a,b   Kim, Jung Woo ^c   Fan, Hung ^a,b  

^a Department of Molecular Biology and Biochemistrya ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PaiChai University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOSYLATED PROTEIN; LA ANTIGEN; AUTOANTIGEN; LA PROTEIN, HUMAN (349 364); LA PROTEIN, HUMAN (349-364); MEMBRANE LIPID; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS PARTICLE; VIRUS RELEASE; ANIMAL; CELL LINE; CELL MEMBRANE; CELL STRAIN 3T3; CHEMISTRY; GENETICS; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RETROVIRUS INFECTION; VIROLOGY; VIRUS SHEDDING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

ANIMALS; AUTOANTIGENS; CELL LINE; CELL MEMBRANE; GENE PRODUCTS, GAG; GLYCOSYLATION; HIV INFECTIONS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; MEMBRANE LIPIDS; MICE; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE INFECTIONS; VIRUS SHEDDING;

EID: 79955111199     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00341-10     Document Type: Article

References (46)

1. Edwards, S. A., and H. Fan. 1979. Gag-related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J. Virol. 30:551-563.
2. Buetti, E., and H. Diggelmann. 1980. Murine leukemia virus proteins expressed on the surface of infected cells in culture. J. Virol. 33: 936-944.
3. Prats, A. C., G. De Billy, P. Wang, and J. L. Darlix. 1989. CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J. Mol. Biol. 205:363-372.
4. Fujisawa, R., F. J. McAtee, J. H. Zirbel, and J. L. Portis. 1997. Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo. J. Virol. 71:5355-5360.
5. Ledbetter, J., R. C. Nowinski, and S. Emery. 1977. Viral proteins expressed on the surface of murine leukemia cells. J. Virol. 22:65-73.
6. Fujisawa, R., F. J. McAtee, K. Wehrly, and J. L. Portis. 1998. The neuroinvasiveness of a murine retrovirus is influenced by a dileucinecontaining sequence in the cytoplasmic tail of glycosylated Gag. J. Virol. 72: 5619-5625.
7. Portis, J. L., R. Fujisawa, and F. J. McAtee. 1996. The glycosylated gag protein ofMuLVis a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein. Virology 226: 384-392.
8. Portis, J. L., G. J. Spangrude, and F. J. McAtee. 1994. Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J. Virol. 68: 3879-3887.
9. Munk, C., V. Prassolov, M. Rodenburg, V. Kalinin, J. Lohler, and C. Stocking. 2003. 10A1-MuLV but not the related amphotropic 4070A MuLV is highly neurovirulent: importance of sequences upstream of the structural Gag coding region. Virology 313: 44-55.
10. Chun, R., and H. Fan. 1994. Recovery of glycosylated gag virus from mice infected with a glycosylated gag-negative mutant of Moloney murine leukemia virus. J. Biomed. Sci. 1: 218-223.
11. Corbin, A., A. C. Prats, J. L. Darlix, and M. Sitbon. 1994. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J. Virol. 68:3857-3867.
12. Low, A., S. Datta, Y. Kuznetsov, S. Jahid, N. Kothari, A. McPherson, and H. Fan. 2007. Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. J. Virol. 81:3685-3692.
13. Kuznetsov, Y. G., S. Datta, N. H. Kothari, A. Greenwood, H. Fan, and A. McPherson. 2002. Atomic force microscopy investigation of fibroblasts infected with wild-type and mutant murine leukemia virus (MuLV). Biophys. J. 83:3665-3674.
14. Nitta, T., Y. Kuznetsov, A. McPherson, and H. Fan. 2010. Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts. Proc. Natl. Acad. Sci. U. S. A. 107: 1190-1195.
15. Pizzato, M. 2010. MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. Proc. Natl. Acad. Sci. U. S. A. 107: 9364-9369.
16. Pfannenschmid, F., V. C. Wimmer, R. M. Rios, S. Geimer, U. Krockel, A. Leiherer, K. Haller, Y. Nemcova, and W. Mages. 2003. Chlamydomonas DIP13 and human NA14: a new class of proteins associated with microtubule structures is involved in cell division. J. Cell Sci. 116: 1449-1462.
17. Ramos-Morales, F., C. Infante, C. Fedriani, M. Bornens, and R. M. Rios. 1998. NA14 is a novel nuclear autoantigen with a coiled-coil domain. J. Biol. Chem. 273:1634-1639.
18. Errico, A., P. Claudiani, M. D'Addio, and E. I. Rugarli. 2004. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum. Mol. Genet. 13: 2121-2132.
19. Yang, K., H. X. Shi, X. Y. Liu, Y. F. Shan, B. Wei, S. Chen, and C. Wang. 2009. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J. Immunol. 182:3782-3792.
20. Higgs, R., J. Ni Gabhann, N. Ben Larbi, E. P. Breen, K. A. Fitzgerald, and C. A. Jefferies. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitinmediated degradation of IRF3. J. Immunol. 181: 1780-1786.
21. Yoshimi, R., T. H. Chang, H. Wang, T. Atsumi, H. C. Morse III, and K. Ozato. 2009. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 182:7527-7538.
22. Wolin, S. L., and T. Cedervall. 2002. The La protein. Annu. Rev. Biochem. 71: 375-403.
23. Maraia, R. J., and R. V. Intine. 2001. Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function. Mol. Cell. Biol. 21:367-379.
24. Raha, T., R. Pudi, S. Das, and M. S. Shaila. 2004. Leader RNA of Rinderpest virus binds specifically with cellular La protein: a possible role in virus replication. Virus Res. 104:101-109.
25. Ali, N., and A. Siddiqui. 1997. The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiatorAUGcodon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. U. S. A. 94: 2249-2254.
26. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Lejbkowicz, D. J. Kenan, E. K. Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993. La autoantigen enhances and corrects aberrant translation of poliovirusRNA in reticulocyte lysate. J. Virol. 67: 3798-3807.
27. Svitkin, Y. V., A. Pause, and N. Sonenberg. 1994. La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 68:7001-7007.
28. Ray, P. S., and S. Das. 2002. La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA. Nucleic Acids Res. 30:4500-4508.
29. Bitko, V., A. Musiyenko, M. A. Bayfield, R. J. Maraia, and S. Barik. 2008. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J. Virol. 82:7977-7987.
30. Vashist, S., M. Anantpadma, H. Sharma, and S. Vrati. 2009. La protein binds the predicted loop structures in the 3' non-coding region of Japanese encephalitis virus genome: role in virus replication. J. Gen. Virol. 90:1343-1352.
31. Tanaka, M., K. Tanji, M. Niida, and T. Kamitani. 2010. Dynamic movements of Ro52 cytoplasmic bodies along microtubules. Histochem. Cell Biol. 133:273-284.
32. Espinosa, A., V. Oke, A. Elfving, F. Nyberg, R. Covacu, and M. Wahren-Herlenius. 2008. The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide. Exp. Cell Res. 314:3605-3613.
33. Craig, A. W., Y. V. Svitkin, H. S. Lee, G. J. Belsham, and N. Sonenberg. 1997. The La autoantigen contains a dimerization domain that is essential for enhancing translation. Mol. Cell. Biol. 17:163-169.
34. Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161.
35. Muriaux, D., J. Mirro, D. Harvin, and A. Rein. 2001. RNA is a structural element in retrovirus particles. Proc. Natl. Acad. Sci. U. S. A. 98: 5246-5251.
36. Pillemer, E. A., D. A. Kooistra, O. N. Witte, and I. L. Weissman. 1986. Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane. J. Virol. 57:413-421.
37. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106:87-102.
38. Pelchen-Matthews, A., B. Kramer, and M. Marsh. 2003. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162: 443-455.
39. Sherer, N. M., M. J. Lehmann, L. F. Jimenez-Soto, A. Ingmundson, S. M. Horner, G. Cicchetti, P. G. Allen, M. Pypaert, J. M. Cunningham, and W. Mothes. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4: 785-801.
40. Morita, E., and W. I. Sundquist. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20:395-425.
41. Yuan, B., X. Li, and S. P. Goff. 1999. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710.
42. Segura-Morales, C., C. Pescia, C. Chatellard-Causse, R. Sadoul, E. Bertrand, and E. Basyuk. 2005. Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding. J. Biol. Chem. 280: 27004-27012.
43. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
44. Maeda, N., Y. Inoshima, D. A. Fruman, S. M. Brachmann, and H. Fan. 2003. Transformation of mouse fibroblasts by Jaagsiekte sheep retrovirus envelope does not require phosphatidylinositol 3-kinase. J. Virol. 77: 9951-9959.
45. Mueller-Lantzsch, N., and H. Fan. 1976. Monospecific immunoprecipitation of murine leukemia virus polyribosomes: identification of p30 protein-specific messenger RNA. Cell 9: 579-588.
46. Mann, R., R. C. Mulligan, and D. Baltimore. 1983. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159.